Skip to content

Carbetocin versus Oxytocin for the Prevention of Postpartum Hemorrhage in Hypertensive Pregnant Women

Carbetocin versus Oxytocin for the Prevention of Postpartum Hemorrhage in Hypertensive Pregnant Women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201909807831604
Enrollment
160
Registered
2019-09-02
Start date
2014-01-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy and Childbirth

Interventions

Sponsors

faculty of medicine suez canal university
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: women aged 18-35 years with term singleton pregnancy prepared for elective lower segment CS at gestational age of = 37 weeks wit h diagnosed hypertensive disorders in pregnancy.

Exclusion criteria

Exclusion criteria: risk factors for excessive blood loss during the surgery (placenta previa, twin pregnancy or presence of uterine fibroid), a history of thromboembolic disorders cases suffering from chronic medical diseases (cardiac, hepatic, renal).

Design outcomes

Primary

MeasureTime frame
•Estimated amount of blood loss. •Incidence and amount of blood transfusion. •Hemoglobin and hematocrit changes pre-and post delivery. •Use of further ecobolics.

Secondary

MeasureTime frame
• Vital signs during and after delivery. • Time of discharge from hospital. • Complications post-delivery (fever, Disseminated Intravascular Coagulation (DIC), maternal infection, ICU admission and cesarean hysterectomy). • Uterine tone and adverse effects. • Neonatal weight. • Neonatal Apgar score. • Neonatal admission to neonatal intensive care.

Countries

Egypt

Contacts

Public Contactomima taha

suez canal university

omimatharwat@yahoo.com01223423685

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026